0 comments on “The Lonely Voices of Autoimmune Disease @StanfordMedX”

The Lonely Voices of Autoimmune Disease @StanfordMedX

Explore a recap of DrBonnie360's Stanford MedicineX 2014 presentation, highlighting the need to use data and digital tools to ignite precision medicine in autoimmune disease. Click the link below: https://wakelet.com/wake/4b074fa4-86ed-4b90-939f-32f1013ade5c

0 comments on “Zephyr Health: Variety and Visualization Creates Useful Information”

Zephyr Health: Variety and Visualization Creates Useful Information

The dimensions of Big Data can be summed up by The Four Vs: Volume, Variety, Velocity, and Veracity.    But however large or diverse one’s data, it can often be hard to find exactly what one needs. As a researcher,…

0 comments on “Syapse: New Power for Patients through Knowledge Sharing”

Syapse: New Power for Patients through Knowledge Sharing

Why do I love Silicon Valley?  Because of the spirit of open collaboration embodied by folks like Halle Tecco, members of XX in Health, and anyone who operates like Jonathan Hirsch. Hirsch is the co-founder and president of Syapse, and…

0 comments on “IBM Information on Demand Conference (Part 1)”

IBM Information on Demand Conference (Part 1)

By Ellen M. Martin For me (lapsed scientist, MBA, life science communications), the most memorable moment at IBM’s November 2013 Information on Demand conference happened at the outset of a Pure Systems (formerly known as Netezza – IBM’s commercial Big Data…

0 comments on “Using Big Data to Personalize the Healthcare Experience: Clinical Trials and Cancer”

Using Big Data to Personalize the Healthcare Experience: Clinical Trials and Cancer

How Big Data is Changing Current Research Methodology: Cancer Cancer is the second leading cause of death in the United States.  Current treatments are ineffective, with over 75% of patients not responding to treatments, despite the $50 billion pharmaceutical companies…

0 comments on “The Role of Big Data in Personalizing the Healthcare Experience: Genomics Part 2”

The Role of Big Data in Personalizing the Healthcare Experience: Genomics Part 2

Human Genome: Then and Now  Research in the field of genomics has come a long way in the past 60 years.  The pioneering effort in studying the human genome and its effect on disease was the Human Genome Project (1990-2003),…

0 comments on “(Part 3) The Data “Revolution” in Healthcare: Obstacles and Opportunities”

(Part 3) The Data “Revolution” in Healthcare: Obstacles and Opportunities

Part Three: Election Day special: Regulatory Obstacles (continued from Part Two) By Ellen Martin Here is a 352-page description of US healthcare regulation as of 2006: Robert I. Field’s Health Care Regulation in America: Complexity, Confrontation, and Compromise. Click Here It is always…

0 comments on “(Part 2) The Data “Revolution” in Healthcare: Obstacles and Opportunities”

(Part 2) The Data “Revolution” in Healthcare: Obstacles and Opportunities

Part Two: Healthcare Structural Issues (continued from Part One) By Ellen Martin First, let’s recognize the fundamental market disconnect between providers, consumers (patients) and (third-party) payers (employers, insurance companies, managed care), which is a fundamental reason that healthcare is not a…

0 comments on “(Part 1) The Data “Revolution” in Healthcare: Obstacles and Opportunities”

(Part 1) The Data “Revolution” in Healthcare: Obstacles and Opportunities

Part One: Introduction By Ellen Martin As evidenced by StrataRx, as well as our Hype and Hope white paper, expectations run high regarding data’s potential to transform healthcare: lower costs, fewer errors, and better patient outcomes. So high, indeed, as…